Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Source: Eur Respir J 2010; 36: 584-593 Year: 2010
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013 Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002 Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
Mortality and associated factors among drug-resistant tuberculosis patients in Portugal, 2000-2016 Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020
Treatment outcome of XDR-TB patients in Iran during 2003-2006 Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
Treatment outcome in multidrug resistant tuberculosis cases at our clinic between 1996-2008 Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Epidemiological and microbiological characteristics of reported cases with multidrug-resistant tuberculosis in the Republic of Bulgaria for the period 2007-2009 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Treatment outcomes of smear-positive pulmonary TB cases in Romania in 2006-2008 Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
The year of 2006 treatment results for soldiers with tuberculosis Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
The year of 2002 treatment results for soldiers with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 646s Year: 2004
The prognosis of patients colonized and infected with pulmonary nontuberculous mycobacteria in Denmark, 1997-2007: a nationwide population-based study Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
The year of 2003 treatment results for soldiers with tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005
The outcome of retreated tuberculosis patients in 2000 and 2001 Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Treatment, drug resistance and delay of diagnosis of TB in Germany 2001-2003: preliminary results of an epidemiological DNA-fingerprinting study Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis Year: 2004
Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
The epidemiological characteristics of tuberculosis (TB) in Romania between 2000-2008 Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
The influence of risk factors on natural history of children‘s primary tuberculosis observed in patients hospitalized in the clinic between 1973-2002 Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005